Cosmetic cross-reference

Sodium Selenite

CAS 10102-18-8

Sodium Selenite (CAS 10102-18-8) is a Phase 3 pharmaceutical compound with 1 bioactivity target and 145 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
1
SOURCE DrugCentral
Adverse signals
145
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Sodium Selenite
CAS Number
10102-18-8
UNII
HIW548RQ3W
InChIKey
BVTBRVFYZUCAKH-UHFFFAOYSA-L
ChEMBL ID
CHEMBL112302
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 3
Late-stage clinical development phase from the compound identifier source.
ChEMBL CHEMBL112302 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE EMBL-EBI ChEMBL 1 bioactivity row

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- IC50 22300 nM 9 -
SOURCE DrugCentral 1 association

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Exposure during pregnancy 26 102.965 10073513

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 2 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
SODIUM SELENITE 56519 SU MTHSPL
sodium selenite 56519 PIN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Sodium Selenite used for in pharmaceutical contexts?

Sodium Selenite (CAS 10102-18-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Sodium Selenite?

Sodium Selenite has 145 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Exposure during pregnancy, Abdominal pain, Acidosis, Administration site nodule, Anal abscess. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Sodium Selenite also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Sodium Selenite with EU status "restricted".

What clinical phase is Sodium Selenite in?

Sodium Selenite is rendered with ChEMBL max phase 3.